• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine.

作者信息

Hidaka Takanori, Fujimura Taku, Watabe Akiko, Hashimoto Akira, Haga Takahiro, Onami Kaoru, Mizuashi Masato, Aiba Setsuya

出版信息

Acta Derm Venereol. 2012 Nov;92(6):654-5. doi: 10.2340/00015555-1354.

DOI:10.2340/00015555-1354
PMID:22504780
Abstract
摘要

相似文献

1
Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine.拉帕替尼和卡培他滨成功治疗HER-2阳性皮肤转移性大汗腺癌
Acta Derm Venereol. 2012 Nov;92(6):654-5. doi: 10.2340/00015555-1354.
2
Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.拉帕替尼联合卡培他滨治疗肝广泛转移患者可使肿瘤迅速缩小
Tumori. 2013 Nov-Dec;99(6):278e-81e. doi: 10.1700/1390.15468.
3
Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
Clin Adv Hematol Oncol. 2011 Jun;9(6):492-500.
4
Scalp angiosarcoma presented as skin-coloured papules.头皮血管肉瘤表现为肤色丘疹。
Acta Derm Venereol. 2014 Jul;94(4):461-2. doi: 10.2340/00015555-1699.
5
Complete response of brain metastases from breast cancer overexpressing Her-2/neu to radiation and concurrent Lapatinib and Capecitabine.曲妥珠单抗联合卡培他滨及放疗治疗 Her-2/neu 过表达乳腺癌脑转移的完全缓解
Breast J. 2010 Nov-Dec;16(6):644-6. doi: 10.1111/j.1524-4741.2010.00980.x.
6
High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.高血清 TGF-α 预示着曲妥珠单抗联合卡培他滨治疗 HER2 阳性乳腺癌的疗效不佳。
Breast Cancer Res Treat. 2011 Jan;125(1):107-14. doi: 10.1007/s10549-010-1200-9. Epub 2010 Oct 9.
7
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.美国食品药品监督管理局药物批准摘要：拉帕替尼联合卡培他滨用于先前接受过治疗的HER-2过表达转移性乳腺癌。
Oncologist. 2008 Oct;13(10):1114-9. doi: 10.1634/theoncologist.2008-0816. Epub 2008 Oct 10.
8
Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.拉帕替尼联合卡培他滨治疗人表皮生长因子受体 2 阳性脑转移。
Am J Ther. 2009 Nov-Dec;16(6):585-90. doi: 10.1097/MJT.0b013e31818bee2b.
9
An Index Case of Cutaneous Hodgkin Lymphoma and Review of the Literature.
Am J Dermatopathol. 2016 Oct;38(10):739-43. doi: 10.1097/DAD.0000000000000543.
10
Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.原发性皮肤CD4/CD8双阴性T细胞受体αβ型T细胞淋巴瘤
Acta Derm Venereol. 2015 Jan;95(1):106-7. doi: 10.2340/00015555-1883.

引用本文的文献

1
Lapatinib ameliorates skin fibrosis by inhibiting TGF-β1/Smad and non-Smad signaling pathway.拉帕替尼通过抑制TGF-β1/Smad和非Smad信号通路改善皮肤纤维化。
Sci Rep. 2025 Mar 11;15(1):8444. doi: 10.1038/s41598-025-92687-1.
2
Treatment of HER2-positive cutaneous apocrine carcinoma of the axilla.HER2阳性腋窝皮肤大汗腺癌的治疗
Int Cancer Conf J. 2024 Jul 6;13(4):348-352. doi: 10.1007/s13691-024-00700-7. eCollection 2024 Oct.
3
When to sweat: A history of chemotherapy in malignant sweat gland tumors. A unique case report and literature review.
何时进行化疗：恶性汗腺肿瘤化疗史。一则独特病例报告及文献综述。
Clin Case Rep. 2023 May 9;11(5):e7182. doi: 10.1002/ccr3.7182. eCollection 2023 May.
4
Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective.皮肤恶性附属器肿瘤的治疗：12年回顾
Cancers (Basel). 2022 Feb 16;14(4):998. doi: 10.3390/cancers14040998.
5
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.具有大汗腺和小汗腺分化的皮肤附件肿瘤的当前诊断和治疗选择。
Int J Mol Sci. 2021 May 11;22(10):5077. doi: 10.3390/ijms22105077.
6
Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy-A case report.系统性抗雄激素治疗成功治愈转移性皮肤大汗腺癌——病例报告
Clin Case Rep. 2020 Oct 30;8(12):3472-3478. doi: 10.1002/ccr3.3434. eCollection 2020 Dec.
7
Cutaneous Adnexal Carcinoma with Apocrine Differentiation: A Challenging Diagnosis and Personalized Treatment with mTOR Inhibitor in a Very Rare Disease.伴大汗腺分化的皮肤附属器癌：一种罕见疾病的挑战性诊断及mTOR抑制剂的个体化治疗
Case Rep Oncol. 2020 Sep 18;13(3):1091-1096. doi: 10.1159/000510097. eCollection 2020 Sep-Dec.
8
Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer.晚期非黑素瘤皮肤癌全身治疗的进展
Front Med (Lausanne). 2019 Jul 10;6:160. doi: 10.3389/fmed.2019.00160. eCollection 2019.
9
Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas.皮肤附件癌各亚型中 PD-L1 表达和 CD8 肿瘤浸润淋巴细胞的异质性。
Cancer Immunol Immunother. 2019 Jun;68(6):951-960. doi: 10.1007/s00262-019-02334-8. Epub 2019 Apr 5.
10
Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.全身化疗和放疗联合地诺单抗成功治疗阴囊晚期原发性大汗腺癌
Case Rep Oncol. 2017 Jan 16;10(1):52-56. doi: 10.1159/000455091. eCollection 2017 Jan-Apr.